EXELIXIS, INC.

By person

27 insiders · 499 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

MORRISSEY MICHAEL

President and CEO

—

$58.19M (59) scheduled

−$58.19M

3,810,385

1.54%

$204.47M

+520.8%

Haley Patrick J.

EVP, Commercial

—

$35.85M (70)

−$35.85M

357,638

0.1443%

$19.19M

+68.7%

Schwab Gisela

Pres, Prod Dev & Med Aff & CMO

—

$34.69M (36) scheduled

−$34.69M

689,078

0.2781%

$36.98M

+375.7%

Hessekiel Jeffrey

EVP & General Counsel

—

$28.18M (41) scheduled

−$28.18M

693,396

0.2798%

$37.21M

+191.6%

Lamb Peter

EVP, Scientific Strategy & CSO

—

$27.46M (26) scheduled

−$27.46M

410,958

0.1659%

$22.05M

+616.6%

Senner Christopher J.

EVP and CFO

—

$24.02M (17) scheduled

−$24.02M

952,317

0.3843%

$51.10M

+887.5%

SCANGOS GEORGE A

Director

—

$23.44M (42)

−$23.44M

714,717

0.2884%

$38.35M

−45.3%

PAPADOPOULOS STELIOS

Director

—

$16.81M (16)

−$16.81M

1,197,595

0.4833%

$64.26M

−3.3%

Aftab Dana

EVP, Research and Development

—

$16.67M (13)

−$16.67M

594,741

0.2400%

$31.91M

+131.3%

JOHNSON DAVID EDWARD

Director

$16.46M (5)

$2.60M (1)

+$13.85M

1,571,438

0.6342%

$84.32M

+72.5%

POSTE GEORGE

Director

—

$12.00M (15) scheduled

−$12.00M

127,199

0.0513%

$6.83M

+64.0%

WILLSEY LANCE

Director

—

$10.20M (13)

−$10.20M

424,415

0.1713%

$22.77M

−25.3%

MARCHESI VINCENT T

Director

—

$8.70M (12) scheduled

−$8.70M

93,989

0.0379%

$5.04M

−21.7%

Smith Julie

Director

—

$8.07M (6) scheduled

−$8.07M

28,957

0.0117%

$1.55M

—

WYSZOMIERSKI JACK L

Director

—

$7.73M (14) scheduled

−$7.73M

284,384

0.1148%

$15.26M

+317.5%

COHEN CHARLES

Director

—

$7.42M (8)

−$7.42M

261,375

0.1055%

$14.03M

+5.3%

Garber Alan M

Director

—

$7.13M (14) scheduled

−$7.13M

35,703

0.0144%

$1.92M

−39.7%

FELDBAUM CARL B

Director

—

$6.83M (14) scheduled

−$6.83M

18,701

0.0075%

$1.00M

−61.6%

Peterson Amy C.

EVP Prod Dev & Med Aff & CMO

—

$3.31M (1) scheduled

−$3.31M

465,393

0.1878%

$24.97M

—

Freire Maria C

Director

—

$2.92M (4) scheduled

−$2.92M

109,186

0.0441%

$5.86M

—

Beckerle Mary C

Director

—

$2.36M (6) scheduled

−$2.36M

16,079

0.0065%

$862.80K

—

Oliver Bob

Director

—

$2.02M (3) scheduled

−$2.02M

29,487

0.0119%

$1.58M

—

Eckhardt Sue Gail

Director

—

$1.87M (6) scheduled

−$1.87M

16,079

0.0065%

$862.80K

—

Hefti Brenda

SVP and General Counsel

—

$1.15M (2) scheduled

−$1.15M

106,762

0.0431%

$5.73M

+17.8%

Heyman Tomas J.

Director

—

$201.25K (1)

−$201.25K

50,649

0.0204%

$2.72M

—

Goodman Vicki L

EVP, Prod Dev & Med Aff &CMO

—

307,654

0.1242%

$16.51M

—

Wright Jacqueline

Director

—

51,756

0.0209%

$2.78M

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

JOHNSON DAVID EDWARD

25 Nov 2025

Director

Buy indirect

27,532

$43.12

$1.19M

JOHNSON DAVID EDWARD

30 May 2024

Director

Buy indirect

225,000

$20.76

$4.67M

JOHNSON DAVID EDWARD

28 May 2024

Director

Buy indirect

200,000

$20.32

$4.06M

JOHNSON DAVID EDWARD

21 Feb 2024

Director

Buy indirect

190,000

$20.70

$3.93M

JOHNSON DAVID EDWARD

27 Nov 2023

Director

Buy indirect

120,409

$21.61

$2.60M

Showing 250 of 499 transactions. The figures above use every one of them.

By person

Individual transactions

What was left out